Artículos del autor

solaci

Acute coronary syndromes

VALIDATE-SWEDEHEART: bivalirudin seems to be losing ground

Another important work that does not see the benefits of bivalirudin over heparin as monotherapy as regards both...
solaci -
HIGHLIGHTS

SPYRAL HTN-OFF MED: Renal Denervation Reloaded?

This work presented at the ESC Congress 2017 held in Barcelona, simultaneously published in The Lancet, seems to...
solaci -
Antithrombotic Anticoagulants

RE-DUAL PCI: Anti-Thrombotic Management in Patients with Atrial Fibrillation and PCI

RE-DUAL PCI outcomes have been published by the  New England Journal of Medicine along with their presentation at...
solaci -
Fellowship

Editorial Comment of Dr. Leandro Lasave on the 8th edition of the José Gabay Fellow Course

Dear colleagues in Latin America,   I am greatly pleased to inform that the 8th edition of the Interventional...
solaci -
Antiplatelet

Dual antiplatelet therapy discontinuation causes more thrombotic events at 12 months

Several randomized studies have shown that dual antiplatelet therapy (DAPT) is as effective to prevent thrombotic events in...
solaci -
Acute coronary syndromes

Early Invasive Strategy Benefits High-Risk Patients

Early angiography is not associated with a reduction in mortality compared with a more delayed invasive strategy...
solaci -
Chronic Ischemic cardiopathy

Striking Finding on Diabetes and Bypass Graft Patency

The higher rate of restenosis in the diabetic population is historic and has been reproduced in all studies...
solaci -
Fellowship

“José Gabay” Course: Interview to Ricardo Lluberas

After the successful 8th edition of the ProEducar “José Gabay” Course (which took place on August 1st, 2017,...
solaci -